Organ transplantation in endocrinology: Islet cells and pancreas;Organtransplantation in der endokrinologie: Inselzellen und pankreas

Internist

Volumn 45, Issue 11, 2004, Pages 1268-1280

  Jaeckel, E ^a   Becker, T ^a   Manns, M P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Beta cell replacement; Immunosuppression; Pancreas transplantation; Tolerance

Indexed keywords

FOLLOW UP; GLUCOSE TRANSPORT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MORBIDITY; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; POSTOPERATIVE PERIOD; QUALITY OF LIFE; REVIEW;

COMORBIDITY; DIABETES MELLITUS; ENDOCRINOLOGY; GRAFT REJECTION; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY DISEASES; PANCREAS TRANSPLANTATION; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 11144257764     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-004-1303-7     Document Type: Review

References (41)

1. Boyle JP, Honeycutt AA, Narayan KM, Hoerger TJ, Geiss LS, Chen H, Thompson TJ (2001) Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care 24: 1936-1940
2. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986
3. Nathan DM (1993) Long-term complications of diabetes mellitus. N Engl J Med 328: 1676-1685
4. The Diabetes Control and Complications Trial Research Group (1995) Adverse events and their association with treatment regimens in the diabetes control and complications trial. Diabetes Care 18: 1415-1427
5. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853
6. Wolfe RA, Ashby VB, Milford EL et al. (1999) Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341: 1725-1730
7. Smets YF, Westendorp RG, van der Pijl JW, de Charro FT, Ringers J, de Fijter JW, Lemkes HH (1999) Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure. Lancet 353: 1915-1919
8. Tyden G, Tollemar J, Bolinder J (2000) Combined pancreas and kidney transplantation improves survival in patients with end-stage diabetic nephropathy. Clin Transplant 14: 505-508
9. Becker BN, Brazy PC, Becker YT et al. (2000) Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease. Kidney Int 57: 2129-2135
10. La Rocca E, Fiorina P, di Carlo V et al. (2001) Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int 60: 1964-1971
11. Minkowsky O (1892) Untersuchungen uber den Diabetes Mellitus nach Extirpation des Pankreas. Berl Klin Wschr 29: 90
12. Williams P (1894) Notes on diabetes treated with extract and by grafts of sheep's pancreas. BMJ 2: 1303-1304
13. Kelly WD, Lillehei RC, Merkel FK, Idezuki Y, Goetz FC (1967) Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery 61: 827-837
14. International Pancreas Transplant Registry (2003) http://www.iptr.umn.edu
15. Sollinger HW, Odorico JS, Knechtle SJ, D'Alessandro AM, Kalayoglu M, Pirsch JD (1998) Experience with 500 simultaneous pancreas-kidney transplants. Ann Surg 228: 284-296
16. Deutsche Stiftung Organtransplantation (2003) http://www.dso.de
17. Frei U, Kahl A, Langrehr J, Neuhaus P (2003) Simultaneous pancreas and kidney transplantation - a chance for diabetic patients with renal failure. Dtsch Med Wochenschr 128: 1237-1242
18. Gruber SA, Katz S, Kaplan B, Clark JH, Chen PC, El-Sabrout R, Kerman RH (2000) Initial results of solitary pancreas transplants performed without regard to donor/recipient HLA mismatching. Transplantation 70: 388-391
19. Cook K, Sollinger HW, Warner T, Kamps D, Belzer FO (1983) Pancreaticocystostomy: an alternative method for exocrine drainage of segmental pancreatic allografts. Transplantation 35: 634-636
20. Limmer A, Ohl J, Kurts C et al. (2000) Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med 6: 1348-1354
21. Douzdjian V, Rice JC, Gugliuzza KK, Fish JC, Carson RW (1996) Renal allograft and patient outcome after transplantation: pancreas-kidney versus kidney-alone transplants in type 1 diabetic patients versus kidney-alone transplants in nondiabetic patients. Am J Kidney Dis 27: 106-116
22. Stratta RJ (1999) Review of immunosuppressive usage in pancreas transplantation. Clin Transplant 13: 1-12
23. Kaufman DB, Leventhal JR, Stuart J, Abecassis MM, Fryer JP, Stuart FP (1999) Mycophenolate mofetil and tacrolimus as primary maintenance immunosuppression in simultaneous pancreas-kidney transplantation: initial experience in 50 consecutive cases. Transplantation 67: 586-593
24. Bechstein WO, Malaise J, Saudek F et al. (2004) Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial. Transplantation 77: 1221-1228
25. Kahl A, Bechstein WO, Lorenz F et al. (2001) Long-term prednisolone withdrawal after pancreas and kidney transplantation in patients treated with ATG, tacrolimus, and mycophenolate mofetil. Transplant Proc 33: 1694-1695
26. Reckard CR, Ziegler MM, Barker CF (1973) Physiological and immunological consequences of transplanting isolated pancreatic islets. Surgery 74: 91-99
27. Najarian JS, Sutherland DE, Matas AJ, Steffes MW, Simmons RL, Goetz FC (1977) Human islet transplantation: a preliminary report.Transplant Proc 9: 233-236
28. Largiader F, Kolb E, Binswanger U, Illig R (1979) Successful allotransplantation of an island of Langerhans. Schweiz Med Wochenschr 109: 1733-1736
29. International Islet Transplant Registry (2004) http://www.med.uni- giessen.de/itr/
30. Lacy PE, Kostianovsky M (1967) Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16: 35-39
31. Lakey JR, Warnock GL, Rajotte RV et al. (1996) Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation 61: 1047-1053
32. Hering BJ, Matsumoto I, Sawada T, Nakano M, Sakai T, Kandaswamy R, Sutherland DE (2002) Impact of two-layer pancreas preservation on islet isolation and transplantation. Transplantation 74: 1813-1816
33. Shapiro AM, Lakey JR, Ryan EA et al. (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343: 230-238
34. Ryan EA, Lakey JR, Paty BW et al. (2002) Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 51: 2148-2157
35. Fiorina P, Folli F, Bertuzzi F et al. (2003) Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients. Diabetes Care 26: 1129-1136
36. Goto M, Johansson H, Maeda A, Elgue G, Korsgren O, Nilsson B (2004) Low molecular weight dextran sulfate prevents the instant blood-mediated inflammatory reaction induced by adult porcine islets. Transplantation 77: 741-747
37. Zulewski H, Abraham EJ, Gerlach MJ et al. (2001) Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 50: 521-533
38. Cheung AT, Dayanandan B, Lewis JT (2000) Glucose-dependent insulin release from genetically engineered K cells. Science 290: 1959-1962
39. Matthews JB, Ramos E, Bluestone JA (2003) Clinical trials of transplant tolerance: slow but steady progress. Am J Transplant 3: 794-803
40. Spitzer TR, Delmonico F, Tolkoff-Rubin N et al. (1999) Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 68: 480-484
41. Herold KC, Hagopian W, Auger JA et al. (2002) Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 346: 1692-1698